Benjamin Rivière
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
Papers in
- Epidemiology 10
- Liver Disease Diagnosis and Treatment 5
- Hepatitis B Virus Studies 2
- Hepatology 10
- Hepatocellular Carcinoma Treatment and Prognosis 7
- Hepatitis C virus research 3
- Co-authors
- Fabrizio Panaro (5 shared papers)Boris Guiu (5 shared papers)Eric Assénat (6 shared papers)Stéphanie Faure (6 shared papers)Francis Navarro (2 shared papers)F. Quénet (3 shared papers)Georges‐Philippe Pageaux (5 shared papers)Olivia Sgarbură (1 shared paper)
- Journals
- Diabetes & Metabolism (1 paper)Alimentary Pharmacology & Therapeutics (1 paper)Journal of Hepatology (1 paper)Transplant International (1 paper)EMBO Molecular Medicine (1 paper)
- Partner nations
- FranceUnited StatesAustralia
In The Last Decade
Benjamin Rivière
21 papers receiving 303 citations
Peers
Comparison fields: 5 of 49
- Hepatology 119
- Transplantation 12
- Epidemiology 112
- Oncology 73
- Rheumatology 38
Countries citing papers authored by Benjamin Rivière
This map shows the geographic impact of Benjamin Rivière's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Rivière with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Rivière more than expected).
Fields of papers citing papers by Benjamin Rivière
This network shows the impact of papers produced by Benjamin Rivière. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Rivière. The network helps show where Benjamin Rivière may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Rivière, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 56 | |
| 2 | 2023 | 43 | |
| 3 | 2018 | 35 | |
| 4 | 2022 | 33 | |
| 5 | 2022 | 29 | |
| 6 | 2014 | 20 | |
| 7 | 2022 | 13 | |
| 8 | 2022 | 13 | |
| 9 | 2020 | 12 | |
| 10 | 2022 | 8 | |
| 11 | 2022 | 7 | |
| 12 | 2024 | 6 | |
| 13 | 2024 | 5 | |
| 14 | 2019 | 5 | |
| 15 | 2021 | 5 | |
| 16 | 2020 | 4 | |
| 17 | 2017 | 3 | |
| 18 | 2019 | 3 | |
| 19 | 2016 | 3 | |
| 20 | 2010 | 1 |
About Benjamin Rivière
Benjamin Rivière is a scholar working on Epidemiology, Hepatology, Surgery, Oncology and Rheumatology, having authored 24 papers that have together received 305 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Liver Disease Diagnosis and Treatment (5 papers), Pancreatic and Hepatic Oncology Research (4 papers), Hepatitis C virus research (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Pancreatitis Pathology and Treatment (2 papers) and Hepatitis B Virus Studies (2 papers). The work is most often cited by research in Hepatology (119 citations), Transplantation (12 citations), Epidemiology (112 citations), Oncology (73 citations) and Rheumatology (38 citations). Benjamin Rivière has collaborated with scholars based in France, United States and Australia. Frequent co-authors include Fabrizio Panaro, Boris Guiu, Eric Assénat, Stéphanie Faure, Francis Navarro, F. Quénet, Georges‐Philippe Pageaux, Olivia Sgarbură, Fabio Giannone and Caterina Cusumano. Their work appears in journals such as Diabetes & Metabolism, Alimentary Pharmacology & Therapeutics, Journal of Hepatology, Transplant International and EMBO Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.